Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 25/2/2021
SIETES contiene 93212 citas

 1 a 20 de 44 siguiente >>
Presentar resultados
Seleccionar todas
1.Tiene citas relacionadas Cita con resumen
Dimmitt SB, Stampfer HG. Polypill for prevention of cardiovascular diseases. Lancet 2020;395:413-4. [Ref.ID 103520]
2.Tiene citas relacionadas Cita con resumen
Roshandel G, Khoshnia M, Poustchi H, Hemming K, Kamangar F, Gharavi A, Ostovaneh MR, Nateghi A, Majed M, Navabakhsh B, Merat S, Pourshams A, Nalini M, Malekzadeh F, Sadeghi M, Mohammadifard N, Sarrafzadegan N, Naemi-Tabiei M, Fazel A, Brennan P, Etemadi A, Boffetta P, Thomas N, Marshall T, Cheng KK, Malekzadeh R. Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial. Lancet 2019;394:24 de agosto. [Ref.ID 103246]
3. Cita con resumen
Messerli FH, Bangalore S, Rimoldi S, Gasowski J, Nussberger J. Are ACE inhibitors acceptable ingredients in polypills?. Lancet 2017;390:26. [Ref.ID 101670]
4.Tiene citas relacionadas Cita con resumen
Huffman MD. The polypill: from promise to pragmatism. PLOS Medicine 2015;12:11 de agosto. [Ref.ID 99454]
5.Tiene citas relacionadas Cita con resumen
Patel A, Cass A, Peiris D, Usherwood T, Brown A, Jan S, Neal B, Hillis GS, Tonkin A, Webster R, Billot L, Bompoint S, Burch C, Burke H, Hayman N, Molanus B, Reid CM, Shiel L, Togni S, Rodgers A, for the Kanyini Guidelines Adherence with the Polypill (Kanyini GAP) Collaboration. A pragmatic randomized trial of a polypill-based strategy to improve use of indicated preventive treatments in people at high cardiovascular disease risk. European Journal of Preventive Cardiology 2015;22:920-30. [Ref.ID 99443]
6.Tiene citas relacionadas Cita con resumen
Selak V, Elley CR, Bullen C, Crengle S, Wadham A, Rafter N, Paraq V, Harwood M, Doughty RN, Arroll B, Milne RJ, Bramley D, Bryant L, Jackson R, Rodgers A. Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care. BMJ 2014;348:g3318. [Ref.ID 98026]
7.Tiene citas relacionadas Cita con resumen
Huffman MD. Fixed dose combinations of cardiovascular drugs. BMJ 2014;348:g3480. [Ref.ID 98023]
8. Cita con resumen
Husten L. FDA advisory panel offers cautious support for polypill. Journal Watch 2014:12 de septiembre. [Ref.ID 97891]
9.Tiene citas relacionadas Cita con resumen
Castellano JM, Sanz G, Peñalvo JL, Bansilal S, Fernández-Ortiz A, Alvarez L, Guzmán L, Linares JC, García F, D'Aniello F, Arnáiz JA, Varea S, Martínez F, Lorenzatti A, Imaz I, Sánchez-Gómez LM, Roncaglioni MC, Baviera M, Smith Jr SC, Taubert K. A polypill strategy to improve adherence: results from the FOCUS project. J Am Coll Cardiol 2014;64:2071-82. [Ref.ID 97057]
10.Tiene citas relacionadas Cita con resumen
Thom S, Poulter N, Field J, Patel A, Prabhakaran D, Stanton A, Grobbee DE, Bots ML, Reddy KS, Cidambi R, Bompoint S, Billot L, Rodgers A, UMPIRE Collaborative Group. Effects of a fixed -dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial. JAMA 2013;310:918-29. [Ref.ID 96053]
11.Tiene citas relacionadas
Gaziano JM. Progress with the polypill?. JAMA 2013;310:910-1. [Ref.ID 96052]
12. Cita con resumen
Anónimo. Polypillomania. Drug Ther Bull 2011;49:13. [Ref.ID 90128]
14.Enlace a cita original Cita con resumen
Marshall T. New of the polypill. BMJ 2008;337:948. [Ref.ID 84316]
15. Cita con resumen
Watts G. What happened to the polypill?. BMJ 2008;337:786. [Ref.ID 84140]
16.Tiene citas relacionadas Cita con resumen
Kaplan NM. Vascular outcome in type 2 diabetes: an ADVANCE?. Lancet 2007;370:804-5. [Ref.ID 81005]
17. Cita con resumen
Anónimo. Polypill goes on trial in Iran. BMJ 2007;334:280. [Ref.ID 79307]
18.Tiene citas relacionadas Cita con resumen
Gaziano TA, Opie LH, Weinstein MC. Prevention of cardiovascular disease with a polypill. Authors' reply. Lancet 2007;369:186. [Ref.ID 78903]
19.Tiene citas relacionadas Cita con resumen
Costantino G, Ceriani E, Rusconi AM, Montano N. Prevention of cardiovascular disease with a polypill. Lancet 2007;369:185-6. [Ref.ID 78902]
20. Cita con resumen
Reddy KS. The preventive polypill - much promise, insufficient evidence. N Engl J Med 2007;356:212. [Ref.ID 78891]
Seleccionar todas
 1 a 20 de 44 siguiente >>